Use of a proteomic approach to link pyruvate kinase M2 expression to oxaliplatin resistance in colorectal cancer patients and human cell lines

被引:0
|
作者
Gines, A.
Martinez-Balibrea, E.
Plasencia, C.
Martinez-Cardus, A.
Musulen, E.
Neamati, N.
Manzano, J. L.
Abad, A.
机构
[1] Hosp Germans Trias & Pujol ICO Badalona, Badalona, Spain
[2] Univ So Calif, Los Angeles, CA USA
关键词
D O I
10.1200/jco.2008.26.15_suppl.4121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4121
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening:A meta-analysis
    Carolin Tonus
    Markus Sellinger
    Konrad Koss
    Gero Neupert
    World Journal of Gastroenterology, 2012, (30) : 4004 - 4011
  • [42] Pyruvate kinase M2 accelerates pro-inflammatory cytokine secretion and cell proliferation induced by lipopolysaccharide in colorectal cancer
    Yang, Peng
    Li, Zongwei
    Li, Hanging
    Lu, Yangxu
    Wu, Haili
    Li, Zhuoyu
    CELLULAR SIGNALLING, 2015, 27 (07) : 1525 - 1532
  • [43] Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
    Mukherjee, Joydeep
    Phillips, Joanna J.
    Zheng, Shichun
    Wiencke, John
    Ronen, Sabrina M.
    Pieper, Russell O.
    PLOS ONE, 2013, 8 (02):
  • [44] Gene expression profile related to oxaliplatin (OXA) intrinsic resistance in a panel of 14 human colorectal cancer (CRC) cell lines
    Martinez-Cardus, A.
    Martinez-Balibrea, E.
    Bandres, E.
    Malumbres, R.
    Manzano, J. L.
    Gines, A.
    Layos, L.
    Quiroga, V.
    Garcia-Foncillas, J.
    Abad, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 359 - 359
  • [45] Cancer-associated mutations in human pyruvate kinase M2 impair enzyme activity
    Liu, Vivian M.
    Howell, Andrea J.
    Hosios, Aaron M.
    Li, Zhaoqi
    Israelsen, William J.
    Vander Heiden, Matthew G.
    FEBS LETTERS, 2020, 594 (04) : 646 - 664
  • [46] Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis
    Li, He
    Xu, Huiyu
    Xing, Rui
    Pan, Yuanming
    Li, Wenmei
    Cui, Jiantao
    Lu, Youyong
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (06)
  • [47] Pyruvate kinase M2 is highly correlated with the differentiation and the prognosis of esophageal squamous cell cancer
    Zhan, C.
    Shi, Y.
    Lu, C.
    Wang, Q.
    DISEASES OF THE ESOPHAGUS, 2013, 26 (07) : 746 - 753
  • [48] 2'-hydroxycinnamaldehyde inhibits cancer cell proliferation and tumor growth by targeting the pyruvate kinase M2
    Yoon, Yae Jin
    Kim, Young-Hwan
    Jin, Yena
    Chi, Seung-Wook
    Moon, Jeong Hee
    Han, Dong Cho
    Kwon, Byoung-Mog
    CANCER LETTERS, 2018, 434 : 42 - 55
  • [49] Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro
    Yuan, Sujuan
    Qiao, Tiankui
    Zhuang, Xibing
    Chen, Wei
    Xing, Na
    Zhang, Qi
    YONSEI MEDICAL JOURNAL, 2016, 57 (06) : 1312 - 1323
  • [50] Tumor M2 pyruvate kinase -: determination in breast cancer patients receiving trastuzumab therapy
    Hoopmann, M
    Warm, M
    Mallmann, P
    Thomas, A
    Göhring, UJ
    Schöndorf, T
    CANCER LETTERS, 2002, 187 (1-2) : 223 - 228